What is Semaglutide (Ozempic, Wegovy) Semaglutide is a GLP-1 receptor drug that the FDA approves for type 2 diabetes care under Ozempic and for long-term weight control under Wegovy
Safety and efficacy for this formulation have not been evaluated by the FDA
At 48 weeks, the 12mg group achieved a mean body weight reduction of 24.2% (approximately 57.8 lbs)
As a defined small molecule, 5-Amino-1MQ is a "tool compound" in the classical pharmacology sense useful for probing NNMT biology specifically
As of June 2026, the FDA's December 2024 Pharmacy Compounding Advisory Committee evaluation concluded that the criteria weighed against placing AOD-9604 (free base) or AOD-9604 acetate on the 503A Bulks List, and AOD-9604 is currently listed as Nominated but Withdrawn from FDA Category 2
I've also worked as an operating room and recovery nurse for one of Orange County's top plastic surgeons, giving me deep knowledge of both invasive and non-invasive body contouring
